SCHEMBL4963593

SCHEMBL4963593

NCC(c1ccc2ccccc2c1)C(O)C1CCCCC1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.70
SLC6A4 P31645 12/20 0.70
SLC6A3 Q01959 12/20 0.70
CYP2D6 P10635 7/20 0.57
CYP3A4 P08684 6/20 0.57
KCNH2 Q12809 4/20 0.57
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
HIF1A Q16665 1/20 0.43
METAP2 P50579 2/20 0.43
GABBR2 O75899 1/20 0.43
GABBR1 Q9UBS5 1/20 0.43
METAP1 P53582 1/20 0.43
MAPT P10636 1/20 0.43
EPHX1 P07099 1/20 0.41
UGT2B7 P16662 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4994288 0.99 SLC6A2 (0.69) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL4996344 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL4992412 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL5001368 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL5001159 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL3732482 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL5001133 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL14115686 0.83 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL14115529 0.83 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
Hydrochloric Acid SCHEMBL5000948 0.82 SLC6A2 (0.97) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200556-A1 Amine Compounds And Inhibiting Neurotrasmitter Reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2008-08-21 US disclosed
EP-1791806-A4 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION (US) 2008-02-20 EP disclosed
EP-1791806-A2 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2007-06-06 EP disclosed
WO-2005120200-A2 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2005-12-22 WO disclosed